CSIMarket Company Name, Ticker, Industry, else..
 
Scinai Immunotherapeutics Ltd  (NASDAQ: SCNI)
 
Price: $1.8600 $-0.09 -4.615%
Day's High: $2.009999990463257 Week Perf: -25.6 %
Day's Low: $ 1.85 30 Day Perf: 618.15 %
Volume (M): 82,500 52 Wk High: $ 3.58
Volume (M$): $ 0 52 Wk Avg: $0.87
Open: $1.93 52 Wk Low: $0.22



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 104
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company conducts therapeutic development activities alongside its contract development and manufacturing organization (CDMO) business. It focuses on expanding its CDMO operations while progressing its therapeutic development programs, including NanoAbs technology. The company's primary revenue source is its CDMO services.


   Company Address: Jerusalem BioPark Jerusalem 0
   Company Phone Number: 8-930-2529   Stock Exchange / Ticker: NASDAQ SCNI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AMGN        1.11% 
BNTX        1.65% 
EXEL        8.37% 
GILD        3.65% 
MRNA        5.48% 
VALN        7.15% 
• View Complete Report
   



Stocks on the Move

Scinai Immunotherapeutics Ltd Trailing Performance and Factors Impacting Their Market Stand

Published Sat, Jul 13 2024 2:33 PM UTC

In recent times, Scinai Immunotherapeutics Ltd has been experiencing a decrease in their market performance, trailing the overall market by 18.79% year to date. This article aims to interpret various news articles to shed light on the factors behind this decline. We will analyze the opinions of veteran traders, recent advancements in cancer immunotherapy, social media contro...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.78
Working Capital Ratio 0.97
Leverage Ratio (MRQ) 0.35
Total Debt to Equity 0.04
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 12,606
Net Income per Employee (TTM) -79,875
Receivable Turnover Ratio (TTM) 14.65
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.08

Profitability Ratios Current
Gross Margin (MRQ) -202.29 %
Operating Margin (MRQ) -575.29 %
Net Margin (MRQ) -633.64 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Scinai Immunotherapeutics Ltd's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.